(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ISTURISA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ISTURISA

ST13

US500000079187535

Class

5

Filing

79187535

Registration

5061675

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

08/06/2026

Trademark type

Word

Nice classes

5

Filing date

03/30/2016

Registration date

10/18/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/08/2023

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

Baar, CH

Examiner

SETTLES LEWIS, SHAILA E

Law office

M50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

RECORDATI AG
NOVARTIS AG

Representatives

Anthony P. Venturino VORYS, SATER, SEYMOUR AND PEASE LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics ; anti-fungal preparations ; antivirals ; cardiovascular pharmaceuticals ; dermatological pharmaceutical products ; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system ; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases ; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculoskeletal system and the genitourinary system ; pharmaceutical preparations for use in hematology and in tissue and organ transplantation ; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions ; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders ; pharmaceutical preparations for the prevention and treatment of kidney diseases ; pharmaceutical preparations for the prevention and treatment of diabetes ; pharmaceutical preparations for the prevention and treatment of hypertension ; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology ; pharmaceutical preparations for use in urology ; pharmaceutical products for ophthalmological use ; pharmaceutical products for the prevention and treatment of cancer and tumors ; Pharmaceutical preparations for the prevention and treatment of allergies ; pharmaceutical products for the prevention and treatment of bone diseases ; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Publications

History of USPTO decisions and trademark events.

32 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/06/2026

RNWL

INTERNATIONAL REGISTRATION RENEWED

05/14/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/23/2026

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

10/18/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/11/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/11/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/11/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/11/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/11/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/11/2023

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

11/20/2023

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

10/13/2023

INPC

INVALIDATION PROCESSED

10/13/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

10/08/2023

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

02/08/2023

71AG

REGISTERED-SEC.71 ACCEPTED

02/08/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/08/2023

ES71

TEAS SECTION 71 RECEIVED

07/28/2022

CHLD

CHANGE OF OWNER RECEIVED FROM IB

04/30/2020

GPNX

NOTIFICATION PROCESSED BY IB

02/10/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/25/2017

FIMP

FINAL DISPOSITION PROCESSED

01/25/2017

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

11/17/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

10/18/2016

PUBO

PUBLISHED FOR OPPOSITION

08/02/2016

NPUB

NOTICE OF PUBLICATION

07/13/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/23/2016

DOCK

ASSIGNED TO EXAMINER

06/21/2016

MAFR

APPLICATION FILING RECEIPT MAILED

06/18/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/14/2016

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/10/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

06/09/2016

Continuous trademark protection

Get notified about every new filing that threatens ISTURISA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.